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INTRODUCTION 
Abnormal uterine bleeding is a common women’s health disorder, 
affects 20% of reproductive age women. Diagnostic evaluations and treatment 
modalities for abnormal uterine bleeding are rapidly evolving the diagnostic 
ones in abnormal uterine bleeding is to exclude endometrial hyperplasia and 
endometrial carcinoma. Sonohysterography and even diagnostic hysteroscopy 
with direct visualization cannot reliably diagnose a malignancy without tissue 
biopsy. Therefore, the gold standard for diagnosis of endometrial hyperplasia 
or carcinoma is tissue biopsy either blind endometrial biopsy or directed 
endometrial biopsy done after sonohysteroscopy or diagnostic hysteroscopy. 
Blind endometrial biopsy with transvaginal ultrasound is the most readily 
available technique but the increasing availability of sonohysterography allows 
more specific anatomical endometrium detail and can diagnose endometrial 
polyps. The echogenicity of the endometrium has certain characteristics during 
various phases of the menstrual cycle, thus enabling the histology to be 
evaluated with precision by examining with transvaginal sonogram During the 
early proliferative phase the endometrial thickness is 2-4mm. Endometrium 
functionalis is hypoechoic or isoechoic and endometrium basalis echogenic. 
During the periovulatory phase the endometrium, has trilaminar appearance or 
triple sign-lumen is echogenic surrounding which there is hypoechoic 
endometrium functionalis and the echogenic endometrium basalis. The 
thickness ranges from 6-12mm. During secretory phase, the whole 
endometrium from basalis to lumen is very echogenic. The greatest thickness is 
achieved during secretory phase measuring upto 14mm in width. In 
postmenopausal patients, thickness less than 4-5mm or thin pencil line echo is 
usually associated with tissue insufficient for diagnosis. In general, normal 
thickness in postmenopausal patients is 4mm..It is now widely accepted that 
dilatation and curettage has little therapeuctic effect on irregular or excessive 
uterine bleeding and the technique has limitations for diagnosis of focal 
endometrial lesions such as polyps, submucous fibroids and adenomyosis. Pre-
operatively the results of transvaginalsonography and sonohysteroscopy may 
help to schedule and plan hysteroscopic surgery and these methods have 
already been proven to be more effective than the traditional dilatation and 
curettage. Furthermore the findings from a transvaginal scan may be used to 
plan the surgical procedure, but there is still a need for a more detailed 
preoperative sonographic diagnosis for example of the size and the depth of 
attachment of submucous fibroids. Cost effective analyses need to be done 
comparing these techniques including the more invasive and potentially 
therapeutic hysteroscopy with resection of polyps and submucosal fibroids. 
Typically, patients with normal Sonohysterography results can be reassured 
and spaced on endometrial biopsy, whereas patients with focal lesions can 
proceed with biopsy and or therapeutic operative hysteroscopy. Patients who 
have normal Sonohysterography results, but still continue to have abnormal 
uterine bleeding should be considered for diagnostic hysteroscopy as it allows 
more complete visualization of the cornual areas. Refinements in diagnosing 
the aetiology of abnormal uterine bleeding allows for increased options for 
targeted treatment thus potentially reducing the number of hysterectomies 
particularly in women with anatomically normal uteri. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
Role of Saline Infusion Sonography in Evaluating Intrauterine and 
Endometrial Pathology 
Parsons et al., in 1996, studied the value of SIS in the diagnosis of endometrial 
abnormalities. 53 patients scheduled for hysterectomy due to abnormal uterine 
bleeding underwent SIS and their findings were confirmed by pathological 
examination of hysterectomy specimen. SIS correctly diagnosed 95% of lesions 
with a sensitivity of 95% and specificity of 100%. 
Bernard et al., in 1997 conducted a study involving 109 premenopausal and 53 
postmenopausal women with the objective to assess the effectiveness of saline 
infusion sonohysterography as a first line investigation of women with uterine 
bleeding. SIS was highly sensitive and specific in the differentiation between 
women with intrauterine lesions and those with normal or atrophic 
endometrium (98.4% and 76.4% respectively).SIS was also accurate in the 
diagnosis of polyps and submucousmyomas (sensitivity 87.8% and 89.6%, 
specificity 90.7 and 95%).SIS and surgery displayed the same reliability in the 
measurement and the localization of the lesions.SIS recognized endometrial 
cancer in only 40% cases. However all these patients had abnormalities in SIS 
which indicated a surgical exploration leading to a zero false negative rate. 
They concluded SIS to be a reliable tool for the investigation of abnormal 
uterine bleeding in perimenopausal women. It can distinguish women who only 
require medical therapy from those who require surgery. The method is easy to 
learn and is well tolerated by the patients. 
Cohen et al., in 1994, studied 15 patients who underwent TVS followed by SIS 
and findings were confirmed by hysteroscopy and pathology. They concluded 
that SIS can differentiate endometrial hyperplasia from polyp with a sensitivity 
of 93%, but cannot differentiate between benign and malignant lesions. 
Saidi et al., in 1997 did a randomized controlled trial in which 68 patients 
underwent either TVS or SIS and findings were confirmed by hysteroscopy / 
pathological examination. SIS was found to have a sensitivity of 90% and 
specificity 83% while TVS was found to have a sensitivity of 95% and 
specificity of 65%. 
Gaucherand et al., 1997 studied 104 patients to compare 
salinesonohysterography in the exploration of the uterine cavity with classical 
transvaginalsonography, hysterography and hysteroscopy. SIS was found to be 
more effective (sensitivity 94%, specificity 98%) than HSG (sensitivity 67%, 
specificity 94%). The difference between TVS and SIS was less marked with 
SIS showing some superiority to TVS (sensitivity 77%, specificity 93%). 
They concluded that SIS represents an improvement over conventional TVS 
and is fully capable of replacing HSG for the study of the uterine cavity. 
Laugh head and Stones et al., in 1997 studied 124 patients with abnormal 
bleeding, and subjected 114 patients to SIS, who had an endometrial thickness 
of > 5 mm in TVS, the findings were correlated with tissue samples and 
concluded that : 
i. SIS afforded better visualisation of the endometrium in patients with 
leiomyomas and polyps 
ii. Can be learnt with ease and quickness by an individual already performing 
ultrasonography. 
iii. Finally SIS was minimally painful, requiring no analgesia, rarely associated 
with infection or any other complication. 
Turner et al., in 1995 screened a group of 30 patients with TVS followed by 
SIS and the findings were confirmed by hysteroscopy and operative procedure 
with pathological examination. They concluded that there is an improved 
demonstration of endometrial polyps and submucous myomas using saline 
enhanced vaginalsonohysterography. 
Goldstein et al., in 1997, under took a study to evaluate anultrasonography 
based triage paradigm for perimenopausal patientswith abnormal uterine 
bleeding. The clinical algorithin usedendovaginal ultrasonography followed by 
saline infusionsonohysterography for selected patients. 153 patients 
weresubjected to SIS, and the findings were compared with hysteroscopy and 
pathological examination. 
They suggested that  
i. Undirected endometrial sampling is unnecessary if TVSclearly shows a 
distinct homogenous endometrium < 5 mmearly with proliferative phase. 
ii. Further a single layer anterior and posterior endometrialmeasurments< 3 mm 
at the time of SIS excludes significantabnormality and contended that 
undirected endometrial samping is only appropriate, if one first demonstrates 
thatthe endometrial process in indeed global and not focal. 
iii. Finally hysteroscopy with curettage should be reserved forthose patients 
with demonstrated focal abnormality on SIS, who are in need of visually 
directed removal or whose ultrasonographic triage was technical unable to 
excludesignificant abnormality. 
Schwarzler P et al., 1998 conducted a study to evaluate the use of 
transvaginalsonography, saline sonohysterography and diagnostic hysteroscopy 
for the assessment of uterine cavity in 100 patients with abnormal uterine 
bleeding. The overall sensitivity of TVS improved after saline enhancement 
from 67 to 87% and the specificity from 89 to 91%. The positive predictive 
value increased from 89 to 92% and the negative predictive value from 71 to 
85%. The use of saline sonohysterography also improved the quality of 
information about the location and size of polyps and submucous fibroids.They 
concluded that the use of saline sonohysterography increasedthe diagnostic 
accuracy of transvaginalsonography to approach that of diagnostic 
hysteroscopy and also provides some additional information. This development 
has implications for the management of uterine bleeding disorders. 
Krampl E; Bourne et al., 2001, evaluated the diagnostic accuracy of 
transvaginalsonography, saline sonohysterography and hysteroscopy in 100 
patients presenting with abnormal uterine bleeding. The detection rate of focal 
intrauterine pathology using Saline hysterography was 94.1% but was 
significantly lower with TVS alone (23.5%).Visual examination at operative 
hysteroscopy yielded no additional information to the detection or exclusion of 
focal lesions than was obtained at outpatient sonohysterography. They 
concluded that outpatient saline sonohysterography may replace diagnostic 
hysteroscopy in many patients with AUB. 
Elizabeth Epstein et al., 2004 conducted a questionnaire based survey to 
determine the management of postmenopausal bleeding in Sweden and 
concluded that more than one – third of the gynecologic departments never 
perform saline Sonohysterography to rule out focal lesions or operative 
hysteroscopy for the removal of such lesions. They stressed the central role of 
saline sonohysterography and hysterosocpy in the new guidelines for the 
management of postmenopausal bleeding and the need to broaden their use. 
Mihm, Lillian et al., 2002 concluded a study to determine the accuracy of 
outpatient endometrial biopsy and saline sonohysterography for the evaluation 
of abnormal uterine bleeding.They demonstrated a high sensitivity and high 
negative predictive value of SIS combined with endometrial biopsy thus 
making it useful for evaluation of abnormal uterine bleeding. It may allow 
some patients to avoid more invasive operative procedures. 
Thus the review of the above cited studies shows less invasive Saline 
sonohysterogram as an upcoming best screening tool for intracavitary 
pathologies in women with AUB as compared to TVS or hysteroscopy and in 
our study we have tried to work on this concept . 
Terms Used to Describe Abnormal Uterine Bleeding 
 
Term Abnormal uterine bleeding pattern 
Oligomenorrhea Bleeding occurs at intervals of > 35 days and usually is caused 
by a prolonged follicular phase. 
Polymenorrhea Bleeding occurs at intervals of < 21 days and may be caused by 
a lutealphase defect. 
Menorrhagia Bleeding occurs at normal intervals (21 to 35 days) but with 
heavy flow (80 mL) or duration (7 days). 
Menometrorrhagia Bleeding occurs at irregular, noncyclic intervals and with heavy 
flow (80 mL) or duration (7 days). 
Amenorrhea Bleeding is absent for 6 months or more in a nonmenopausal 
woman. 
Metrorrhagia or 
bleeding intermenstrual 
Irregular bleeding occurs between ovulatory cycles; causes to 
consider include cervical disease, intrauterine device, 
endometritis, polyps, submucousmyomas, endometrial 
hyperplasia, and cancer. 
midcycle spotting Spotting occurs just before ovulation, usually because of a 
decline in the estrogen level. 
Postmenopausal 
bleeding 
Bleeding recurs in a menopausal woman at least 1 year after 
cessation of cycles. 
Acute emergent 
abnormal uterine 
bleeding 
Bleeding is characterized by significant blood loss that results in 
hypovolemia (hypotension or tachycardia) or shock. 
Dysfunctional uterine 
bleeding 
This ovulatory or anovulatory bleeding is diagnosed after the 
exclusion of pregnancy or pregnancy-related disorders, 
medications, iatrogenic causes, obvious genital tract pathology, 
and systemic conditions. 
Evaluation of Abnormal Uterine Bleeding 
 
Diagnostic 
step Pertinent signs, symptoms, and tests Conditions 
History Pelvic pain Miscarriage, ectopic 
pregnancy, PID, trauma, 
sexual abuse or assault 
Nausea, weight gain, urinary frequency, 
fatigue 
Pregnancy 
Weight gain, cold intolerance, constipation, 
fatigue 
Hypothyroidism 
Weight loss, sweating, palpitations Hyperthyroidism 
Easy bruising, tendency to bleed Coagulopathy 
Jaundice, history of hepatitis Liver disease 
Hirsutism, acne, acanthosisnigricans, 
obesity 
Polycystic ovary syndrome 
Postcoital bleeding Cervical dysplasia, 
endocervical polyps 
Galactorrhea, headache, visual-field 
disturbance 
Pituitary adenoma 
Weight loss, excessive exercise, stress Hypothalamic suppression 
Physical 
examination 
Thyromegaly, weight gain, edema Hypothyroidism 
Thyroid tenderness, tachycardia, weight 
loss, velvety skin 
Hyperthyroidism 
Bruising, jaundice, hepatomegaly Liver disease 
Enlarged uterus Pregnancy, leiomyoma, 
uterine cancer 
Firm, fixed uterus Uterine cancer 
Adnexal mass Ovarian tumor, ectopic 
pregnancy, cyst 
Uterine tenderness, cervical motion 
tenderness 
PID, endometritis 
Laboratory 
tests 
Beta-subunit human chorionic gonadotropin Pregnancy 
Complete blood count with platelet count 
and coagulation studies 
Coagulopathy 
Liver function tests, prothrombin time Liver disease 
Thyroid-stimulating hormone Hypothyroidism, 
hyperthyroidism 
Prolactin Pituitary adenoma 
Blood glucose Diabetes mellitus 
DHEA-S, free testosterone, 173-
hydroxyprogesterone if hyperandrogenic 
Ovarian or adrenal tumor 
Papanicolaou smear Cervical dysplasia 
Cervical testing for infection Cervicitis, PID 
Imaging and 
tissue 
Endometrial biopsy or dilatation and 
curettage 
Hyperplasia, atypia, or 
adenocarcinoma 
Diagnostic 
step Pertinent signs, symptoms, and tests Conditions 
sampling 
 
 
 
Transvaginal ultrasonography Pregnancy, ovarian or 
uterine tumors 
Saline-infusion sonohysterography Intracavitary lesions, polyps, 
submucous fibroids 
Hysteroscopy Intracavitary lesions, polyps, 
submucous fibroids 
 
HYSTEROSCOPY: 
The hysteroscope can be used to aid the diagnosis or to direct the 
performance of a variety of intrauterine procedures.Developments in the design 
of endoscopes have resulted in smaller diameter instruments that retain the 
ability to provide a high quality image.Such developments further facilitate the 
use of hysteroscopy as office procedure. 
DIAGONOSTIC HYSTEROSCOPY :  
The goal of evaluation of uterine cavity is to either a sample of 
endometrium usually for the dtetection of hyperplasia or  neoplasia or to 
identify structural abnormalities such as polyps, myomas or a uterine septum. 
OPERATIVE HYSTEROCPY:  
A number of intrauterine procedures can be performed under endoscopic 
guidance including adhesiolysis, sterilisation,division of septum,myoma 
resection,endometrial destruction through Nd:YAG laser,or radiofrequency 
resection,dessication,or vaporisation,removal of foreign bodies,or to position 
occluding devices in fallopian tube for sterilisation. 
 
Rigid hysteroscopes :  
Rigid hysteroscopes are the most commonly used instruments. Their 
wide range of diameters allows for in-office and complex operating-room 
procedures. Of the narrow options (3-5 mm in diameter), the 4-mm scope 
offers the sharpest and clearest view. It accommodates surgical instruments but 
is small enough to require minimal cervical dilation. In addition, patients 
tolerate this instrument well with only paracervical block anesthesia.  
Flexible hysteroscopes: 
The flexible hysteroscope is most commonly used for office 
hysteroscopy. It is notable for its flexibility, with a tip that deflects over a range 
of 120-160°. Its most appropriate use is to accommodate the irregularly shaped 
uterus and to navigate around intrauterine lesions. It is also used for diagnostic 
and operative procedures.  
Energy Sources:  
Monopolar and bipolar electricity, as well as laser energy, all have uses 
in hysteroscopy. 
MEDIA :  
Gases Carbon dioxide (CO2) is rapidly absorbed and easily cleared from 
the body by respiration. The refractory index of CO2 is 1.0, which allows for 
excellent clarity and widens the field of view at low magnification. The gas 
easily flows through narrow channels in small-diameter scopes, making it 
useful for office-based diagnostic hysteroscopy. However, this method offers 
no way to clear blood from the scope.  
Fluids :  
The advantage of fluid over gas is the symmetric distention of the uterus 
with fluid and its effective ability to flush blood, mucus, bubbles, and small 
tissue fragments out of the visual field .0.9% sodium chloride solution and 
lactated Ringer solution, 5% Mannitol, 3% sorbitol and 1.5% glycine , Dextran 
70.  
POTENTIAL INDICATIONS FOR Diagnostic hysteroscopy 
- Unexplained AUB  
- Infertility cases with abnormal hysterography or TVS and in unexplained infertility 
-  Recurrent spontaneous abortions 
RISKS: 
The risks are more with operative hysteroscopy than  diagnostic 
hysteroscopy.most patients have slight vaginal bleeding,lower abdominal 
cramps.risks related to anaesthesia,perforation which range from failure to 
complete the procedure to haemorrhage,injury to intestines or urinary tract.Air 
embolus associated with gaswous or fluid distension media.  
Advantages 
 
• direct visualization of pathology 
• accurate localization of lesion 
• to take biopsy from lesion (good volume of tissue obtained) 
TRANSVAGINAL ULTRASOUND 
Today the modern Obstetrics & Gynaecology is not complete without 
the aid of diagnostic sonography   The first report of Transvaginal sonography 
is attributed  to Kvatochwil in 1969. Development of Transvaginal sonogaphy 
was delayed  until 1980s when it was used to evaluate infertility problems in 
Japan and in  United States. The advent of Transvaginal probes in 1985 enabled 
the use of higher frequencies in sonographic evaluation of female pelvis As 
Transvaginal  sonography is employing higher frequencies (5-7.5 Mhz) 
improved image resolution is obtained. This higher frequencies provide 
superior axial and lateral  resolution. The abdominal sonography is not that 
much useful for the  gynaecologist willing to image female organs in the true 
pelvis as bending of the  pelvic bone covered by gut and omentum will hinder 
the view. The  Mandated Distension of urinary bladder creating acoustic 
window to view the pelvic organs further distorts the normal anatomy. Obesity, 
Retroverted uterus create further obstruction giving difficulties to visualise the 
target organ. A larger distance produces more attenuation of ultrasonic beam 
resulting in inferior image quality. Transvaginal ultrasonography has been 
explored as an alternative technique to indirectly visualize the endometrium. 
Endometrial thickness is measured as the maximum anterior – posterior 
thickness of the endometrial echo on a long-axis transvaginal view of the 
uterus. Because transvaginal ultrasonography in patients with bleeding has an 
extremely high negative predictive value, it is a reasonable first approach. 
Transvaginal ultrasonography may reveal leiomyoma, endometrial thickening, 
or focal masses. Although this imaging modality may miss endometrial polyps 
and submucous fibroids, it is highly sensitive for the detection of endometrial 
cancer (96 percent) and endometrial abnormality (92 percent). Compared with 
dilatation and curettage, endometrial evaluation with transvaginal 
ultrasonography misses 4 percent more cancers, but it may be the most cost-
effective initial test in women at low risk for endometrial cancer who Have 
abnormal uterine bleeding that does not respond to medical management.  
ENDOMETRIAL THICKNESS 
A measurement of total endometrial thickness should include both the 
anterior and posterior layer of the endometrium. Caliper placement should be  
perpendicular to the endometrial cavity echo. 
At the end of menstruation - 1 to 4 mm 
Proliferative phase - 4 to 8 mm 
Secretory phase - 12 to 14 mm 
Post menopausal women - Thin endometrium. Thickness should not be more 
than 5 mm 
Patient on Estrogen Therapy - Thickness should not be more than 
10 mm 
 
SALINE INFUSIONSONOGRAM 
 
Saline-infusion sonohysterography bolsters the diagnostic power of 
transvaginal ultrasonography. This technique entails ultrasound visualization 
after 5 to 10 mL of sterile saline has been instilled in the endometrial cavity. Its 
sensitivity and specificity for endometrial cancer are comparable with the high 
sensitivity and specificity of diagnostic hysteroscopy. Saline-infusion 
sonohysterography is more accurate than transvaginal ultrasonography in 
diagnosing intracavitary lesions and is more accurate than hysteroscopy in 
diagnosing endometrial hyperplasia. The combination of directed endometrial 
biopsy and saline-infusion sonohysterography results in a sensitivity of 95 to 
97 percent and a specificity of 70 to 98 percent for the identification of 
endometrial abnormality.Saline  provides an acoustic window, which 
delineatesthe intraluminal and endometrial pathology very  well and aids in a 
correct diagnosis. Use of a negative contrast like saline is better than a positive 
ultrasound contrast in the evaluation of the endometrial pathology. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
AIM OF THE STUDY 
 
To evaluate the diagnostic accuracy of transvaginal ultrasonogram with 
sonohysterography and hysteroscopy for the screening of intracavitary 
pathologies in women with abnormal uterine bleeding and to correlate the 
findings with the histopathological specimens of the endometrium obtained by 
dilation and curettage or hysterectomy. 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
The study included 200 women who had come to the Institute of Social 
Obstetrics and Government Kasturba Gandhi hospital with complaints of 
abnormal uterine bleeding were selected, admitted and subjected for 
transvaginal ultrasonogram followed by sonohysterography using saline 
instilled through an endocervically placed catheter in sequence of the same day 
of admission. 24 hours later diagnostic hysteroscopy was performed under 
intravenous sedation and endometrial tissue collected for histology by 
D&C/directed biopsies. 
This is prospective one year study conducted September 2010 to August 
2011 and the study was conducted in our hospital after getting approval from 
the ethical committee of Madras Medical College.  
PATIENT SELECTION: 
Inclusion criteria: 
• Only parous women of age 25years to 45 years 
• No demonstratable pelvic pathology 
• Not on hormonal therapy 
• No evidence of haematological disorder/medical illness/surgical 
complications so as to avoid any anaesthetic or surgical risk during 
hysteroscopy 
 
 
Exclusion criteria: 
• Nulliparous women 
• Age more than 45 years 
• Post menopausal bleeding  
• Associated adnexal, pelvic pathologies like fibroid uterus 
• IUCD in situ  
• History of PID, endometriosis, tuberculosis,  
• Severe anaemia due to AUB requiring immediate ICU care 
• Profuse bleeding requiring emergency therapeutic curettage 
 
PROCEDURE:    
Detailed history taking was done (as in Proforma) Informed consent is 
obtained for all the patients. 
 
PERFORMING TRANSVAGINAL ULTRASOUND 
TVS is done using 5 megahertz curvilinear probe. Patients were asked to 
empty the bladder before the procedure. Patient is dorsal position with knees 
semi flexed. TVS probe covered by condom painted with acoustic gel gently 
introduced into introitus and saggital and coronal section of the uterus used. 
Endometrial thickness and other uterine or adnexal pathologies were looked for 
and findings noted. 
 
 
PERFORMING SONOHYSTEROGRAPHY: 
Patients in same dorsal position, a sterile SIMS speculum is introduced 
vaginally. Cervix and vagina disinfected with betadine solution. Anterior lip of 
cervix is held with vulsellum and a 6F Foleys catheter prefilled with sterile 
saline introduced into uterine cavity transcervically to avoid air entering uterine 
cavity. 2 ml distilled water was used to inflate the Foleys bulb which was 
placed in the lower most part of the uterine cavity to avoid backflow of saline. 
After removing the speculum the TVS probe was gently introduced posterior to 
the catheter. Under ultrasound guidance the uterine cavity was distended with 
10ml sterile normal saline injected through the Foleys.  
Findings noted:  
Uterus – length, AP measurements, transverse dimensions, endometrial 
thickness, any polyps adenomyosis, or other intracavitary pathologies, their 
number size position noted.  
The maximum Endometrial thickness was the distance in millimetres 
from one myometrial endometrial interface to the other across the uterine 
cavity measured at the level of the fundus. In SIS, the anterior and posterior 
endometrial thickness were measured separately and added for total 
endometrial thickness. A cut of value of 14mm was set to delineate normal 
from hyperplastic endometrium on ultrasound as per previous studies. 
All the patients who underwent the above procedures tolerated well. 
There was no need for cervical dilation or local anaesthesia in any of the 
patients for catheter insertion. Some patients complained of mild abdominal 
cramps which required oral analgesics(NSAIDS).  
All these 200 patients who underwent TVS and SIS were posted for 
hysteroscopy under IV sedation the next day. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
USG FINDINGS: 
NUMBER FINDINGS TYPES 
0 NORMAL EMthickness less than or equal to 
14 mm 
1 ABNORMAL 1. ENDOMETRIAL 
HYPERPLASIA 
2. ENDOMEDTRIAL POLYP 
3. SUBMUCOUS FIBROIDS 
 
PERFORMING HYSTEROSCOPY 
 
• Patients were advised to have light dinner before 10 PM on night prior 
to hysteroscopy and remain nil per oral since then 
• Preparation done as for other surgical procedures 
• Informed consent for the procedure & anaesthetic assessment for 
hysteroscopy and D& C obtained. 
• Patient is examined and reassessed by anaesthetist in the theatre. After a 
routine examination which includes vital parameters such as 
Temperature, Pulse, blood pressure, cardio vascular and Respiratory 
system examination. 
Positioning:  
hysteroscopy is best performed with the patient in the dorsal lithotomy 
position. A 10% povidone-iodine  vaginal and perineum preparation is 
preferred for hysteroscopic procedures 
ANAESTHESIA: 
Under iv sedation using ketamine  
The hysteroscope is gently inserted through the external cervical os, and 
the endocervical canal is inspected. Insufflation medium  ringer lactate 
injected, allowing visualization of the cavity,which appears as a dark spot (the 
location of this “dark spot” depends on the angle of scope and the position of 
the uterus). The hysteroscope is directed toward this dark spot until the cavity 
is entered. The flow of medium is adjusted so the cavity is adequately 
distended.. The cervical mucosa is whitish  in colour which differentiates it 
from the uterine cavity lining. The entire uterine cavity,cornua ,papillary and 
glandular structure of the mucosa be studied. Systematic inspection of the 
cavity is performed andshould include examination of the fundus, anterior and 
posterior walls, lateral walls, both tubal ostia, and the lower uterine segment.  
The endometrium was classified as abnormal if it appeared to be excessively 
thick, irregular and hypervascular,with widened glandular openings. A polyp 
was defined as a smooth, firm  and poorly vascularized mucous or fibrous 
tumor that could be single or multiple, sessile or pedunculated. Their color was 
required to be similar to that of the surrounding endometrium, with no 
glandular orifices present. A submucous fibroid was defined as a smooth, 
irregular shaped, sessile or pedunculated tumor that distorted the regular 
contour of an otherwise normal uterine cavity. The covering endometrium was 
required to be pale and transparent for the obvious visualization of surface 
blood vessels. 
Hysteroscopic diagnosis of endometrial hyperplasia was based on one or more 
of the following criteria. 
1. Focal or diffuse increase in endometrial thickness 
2. Irregular aspects of endometrial surface 
3. Cystic formations protruding into endometrial surface 
4. Increased dilated superficial vessels on panaromic view 
The procedure was completed after obtaining directed biopsies from 
lesions that gave the  impression of focal hyperplasia or from all the 
uterine walls in case of diffuse hyperplasia. 
 
Dilatation and Curettage done for all the patients 
 
Under anaesthesia endometrial curettage was done and curettings and 
directed biopsy specimens  were sent for histopathological examination. 
All the patients in our study tolerated the procedure well and were 
discharged the next day. They were asked to come for follow up a week later to 
collect the HPE report and further planning for AUB management.. 
 
 
 
 
 
 
 
  
 
RESULTS AND ANALYSIS 
In our study 200 patients with AUB who  were subjected to trans 
vaginal usg followed by saline infusion sonogram  and hysteroscopy  were 
reviewed a week later with HPE result of the D&C/directed endometrial lesion 
biopsy .Among these 200 patients,91  patients were selected for  hysterectomy  
.(i.e) those patients who had abnormal findings in the above investigations and 
also for  patients  with h/o long standing AUB not ready for regular follow 
up.and  who wanted hysterectomy . 
The findings of TVS,SIS and hysteroscopy were correlated with 
hysterectomy which is considered the gold standard  and the diagnostic 
accuracy of individual tests was evaluated..  
The results were subjected to statistical analysis and they are as follows 
 
 
 
 
 
  
TABLES AND CHARTS 
TABLE 1 SIS Findings Vs AGE 
 
SIS N Mean Std. Deviation Std. Error Mean 
 
Age 
0 145 39.49 3.893 .323 
1 55 41.11 2.608 .352 
 
Abnormal SIS was found in 55 patients and the mean age group was found to 
be 41 in our study 
 
TABLE 2  SIS Vs Duration of complaints 
 SIS N Mean Std. Deviation 
Std. Error 
Mean 
DURATION OF 
COMPLAINT ( months) 
0 145 7.14 1.942 .161 
1 55 7.30 1.870 .254 
 
Mean duration of complaint among the patients with abnormal SIS findings was 7 
months in our study 
 
 
 
  
 
TABLE 3: TVS Findings VS age & duration of complaints 
 
Abnormal TVS found in 56 patients  and the mean age group was 41 in our study.The 
mean duration of complaints among the abnormal group was 7 months. 
 
TABLE 4 Hysteroscopy Vs age &duration of complaints 
 
Abnormal hysteroscopy found in 51 patients  and the mean age group was 41 in our 
study.The mean duration of complaints among the abnormal group was 7 months. 
 
 
 
 
TVS abn/  norm N Mean 
Std. 
Deviation 
Std. Error 
Mean 
DURATION OF COMPLAINT in months  144 7.14 1.945 .162 
1 55 7.29 1.863 .251 
AGE 0 144 39.47 3.895 .325 
1 56 41.13 2.608 .349 
 HYSTER 
SCOPY     
abn/nor N Mean Std. Deviation Std. Error Mean 
DURATION OF COMPLAINT 
(months ) 
0 149 7.11 1.937 .159 
1 50 7.38 1.872 .265 
AGE 0 149 39.55 3.879 .318 
  
 
TABLE 5 :  TVS Findings Vs age group 
 
 Tvs 
 
  0 1 2 3 Total 
Age 1 Count 3 0 0 0 3 
% within Tvs 2.1% .0% .0% .0% 1.5% 
% of Total 1.5% .0% .0% .0% 1.5% 
2 Count 24 0 0 0 24 
% within Tvs 16.7% .0% .0% .0% 12.0% 
% of Total 12.0% .0% .0% .0% 12.0% 
3 Count 52 17 1 2 72 
% within Tvs 36.1% 42.5% 10.0% 33.3% 36.0% 
% of Total 26.0% 8.5% .5% 1.0% 36.0% 
4 Count 65 23 9 4 101 
% within Tvs 45.1% 57.5% 90.0% 66.7% 50.5% 
% of Total 32.5% 11.5% 4.5% 2.0% 50.5% 
 Total Count 144 40 10 6 200 
% within Tvs 100.0% 100.0% 100.0% 100.0% 100.0% 
% of Total 72.0% 20.0% 5.0% 3.0% 100.0% 
 
AGE GROUP 
1-----<30YR 
2-----31-35YR 
3-----36-40YR 
4----->41YR 
 
  FROM THE ABOVE TABLE :20%patients(40) had endometrial 
hyperplasia.5% (10) had endometrial polyp.3%(6) had submucous 
fibroids.50%(101) patients with abnormal TVS finding belonged to >40 years 
in our study. 
Chi square value  17.467 and P value was 0.042  which is significant. 
 
 
 
 
 
 
 
 
 
  
 
TABLE 6 :  SIS Findings Vs age group 
 
 
 SIS  
 0 1 2 3 Total 
Age 1 Count 3 0 0 0 3 
% within SIS 2.1% .0% .0% .0% 1.5% 
% of Total 1.5% .0% .0% .0% 1.5% 
2 Count 24 0 0 0 24 
% within SIS 16.7% .0% .0% .0% 12.0% 
% of Total 12.0% .0% .0% .0% 12.0% 
3 Count 51 14 6 1 72 
% within SIS 35.4% 48.3% 27.3% 20.0% 36.0% 
% of Total 25.5% 7.0% 3.0% .5% 36.0% 
4 Count 66 15 16 4 101 
% within SIS 45.8% 51.7% 72.7% 80.0% 50.5% 
% of Total 33.0% 7.5% 8.0% 2.0% 50.5% 
 
Total Count 144 29 22 5 200 
% within SIS 100.0% 100.0% 100.0% 100.0% 100.0% 
% of Total 72.0% 14.5% 11.0% 2.5% 100.0% 
 
FROM THE ABOVE TABLE: 29% patients(14) had endometrial 
hyperplasia.11% (22) had endometrial polyp.2%(5) had submucous 
fibroids.50%(101) patientswith abnormal SIS findings  belonged to >40 years 
in our study.  
Chi square value: P value was 0.062 
 
 
  
 
 
 
 
 
 
 
 
 
 TABLE 7: HYSTEROSCOPY VS AGE 
 
 
 HYSTEROSCOPY         TYPES  
 0 1 2 3 Total 
Age 
1 
Count 3 0 0 0 3 
% within Hysteroscopy         types 2.0% .0% .0% .0% 1.5% 
% of Total 1.5% .0% .0% .0% 1.5% 
2 
Count 24 0 0 0 24 
% within Hysteroscopy         types 16.0% .0% .0% .0% 12.0% 
% of Total 12.0% .0% .0% .0% 12.0% 
3 
Count 52 13 6 1 72 
% within Hysteroscopy         types 34.7% 50.0% 31.6% 20.0% 36.0% 
% of Total 26.0% 6.5% 3.0% .5% 36.0% 
4 
Count 71 13 13 4 101 
% within Hysteroscopy         types 47.3% 50.0% 68.4% 80.0% 50.5% 
% of Total 35.5% 6.5% 6.5% 2.0% 50.5% 
 
Total 
Count 150 26 19 5 200 
% within Hysteroscopy         types 100.0% 100.0% 100.0% 100.0% 100.0% 
% of Total 75.0% 13.0% 9.5% 2.5% 100.0% 
 
FROM THE ABOVE TABLE: 13 % patiet(26) had endometrial hyperplasia.9% (19) 
had endometrial polyp. 2.5% (5)  had submucous fibroids.50%(101) patient  with 
abnormal hysteroscopy findings belonged to >40 years in our study. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
TABLE 8 : TVS Vs Previous h/o AUB 
 TVS abn/  norm  
   0 1 Total 
Previous h/o AUB 0 Count 76 24 100 
% within TVS abn/  norm 52.8% 42.9% 50.0% 
% of Total 38.0% 12.0% 50.0% 
1 Count 68 32 100 
% within TVS abn/  norm 47.2% 57.1% 50.0% 
% of Total 34.0% 16.0% 50.0% 
 Total Count 144 56 200 
% within TVS abn/  norm 100.0% 100.0% 100.0% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Out of the 100 patients who had previous h/o AUB ,32 patients had abnormal 
TVS findings whereas 68 patients had normal TVS 
 
 
  
 
 
 
TABLE 9 : SIS Vs Previous h/o AUB 
Crosstab 
 Sis  
 0 1 Total 
Previous h/o AUB 0 Count 75 25 100 
% within Sis 51.7% 45.5% 50.0% 
% of Total 37.5% 12.5% 50.0% 
1 Count 70 30 100 
% within Sis 48.3% 54.5% 50.0% 
% of Total 35.0% 15.0% 50.0% 
 Total Count 145 55 200 
% within Sis 100.0% 100.0% 100.0% 
 
Out of the 100 patients who had previous h/o AUB ,30 patients had abnormal 
SIS findings whereas 70 patients had normal SIS. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
TABLE 10 : HYSTERO SCOPY  Vs Previous h/o AUB 
 
HYSTERO SCOPY     
ABN/NOR  
 
0 1 Total 
Previous h/o AUB 0 Count 78 22 100 
% within HYSTERO SCOPY     
abn/nor 
52.3% 43.1% 50.0% 
% of Total 39.0% 11.0% 50.0% 
1 Count 71 29 100 
% within HYSTERO SCOPY     
abn/nor 
47.7% 56.9% 50.0% 
% of Total 35.5% 14.5% 50.0% 
 Total Count 149 51 200 
% within HYSTERO SCOPY     
abn/nor 
100.0% 100.0% 100.0% 
% of Total 74.5% 25.5% 100.0% 
 
Out of the 100 patients who had previous h/o AUB ,29 patients had abnormal 
HYSTEROSCOPY findings whereas 71 patients had normal 
HYSTEROSCOPY findings 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
TABLE 11 : HPE  Vs Previous h/o AUB 
 
 Hpe Nor/Abn  
 0 1 Total 
Previous h/o AUB 0 Count 74 26 100 
% within Hpe nor/abn 52.9% 43.3% 50.0% 
% of Total 37.0% 13.0% 50.0% 
1 Count 66 34 100 
% within Hpe nor/abn 47.1% 56.7% 50.0% 
% of Total 33.0% 17.0% 50.0% 
 Total Count 140 60 200 
% within Hpe nor/abn 100.0% 100.0% 100.0% 
% of Total 70.0% 30.0% 100.0% 
 
Out of the 100 patients who had previous h/o AUB, 66 patients had abnormal 
hpe findings whereas 34 patients had normal hpe findings. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
TABLE 12 : TVS  Vs Hysterectomy 
 HYSTERECTOMY 
FINDINGS 
 
 0 1 Total 
TVS abn/  norm 0 Count 29 6 35 
% within TVS abn/  norm 82.9% 17.1% 100.0% 
% within Hysterecctomy  
findings 
87.9% 10.3% 38.5% 
% of Total 31.9% 6.6% 38.5% 
1 Count 4 52 56 
% within TVS abn/  norm 7.1% 92.9% 100.0% 
% within Hysterecctomy 
findings 
12.1% 89.7% 61.5% 
% of Total 4.4% 57.1% 61.5% 
 Total Count 33 58 91 
% within TVS abn/  norm 36.3% 63.7% 100.0% 
% within Hysterecctomyfindings 100.0% 100.0% 100.0% 
% of Total 36.3% 63.7% 100.0% 
  
 
 
Hysterectomy group  
0—normal (proliferative/secretory endometrium) 
1—abnormal (EMhyperplasia,EM polyp,submucous fibroid) 
Out of the 56 patients with abnormal finding on TVS 52(92%) had abnormal findings 
in hysterectomy. 6 (17%) patients with normal TVS findings had abnormality in 
hysterectomy . 
 
Chi-Square Tests 
 Value Exact Sig  (2- sided) 
McNemar Test  .754a 
McNemar Test 91  
 
 
 
 
 
 
 
 
 
 TABLE 13 :  SIS Vs hysterectomy 
 Hysterectomy Findings  
0 1 Total 
SIS 0 Count 31 5 36 
% within SIS 86.1% 13.9% 100.0% 
% within Hysterecctomy  
findings 
93.9% 8.6% 39.6% 
% of Total 34.1% 5.5% 39.6% 
1 Count 2 53 55 
% within SIS 3.6% 96.4% 100.0% 
% within Hysterecctomy 
findings 
6.1% 91.4% 60.4% 
% of Total 2.2% 58.2% 60.4% 
 Total Count 33 58 91 
% within SIS 36.3% 63.7% 100.0% 
% within Hysterecctomy 
findings 
100.0% 100.0% 100.0% 
 
Chi-Square Tests 
 Value Exact Sig  (2- sided) 
McNemar Test  .453a 
McNemar Test 91  
 
Out of the 55 patients with abnormal finding on SIS 53(96%) had abnormal findings 
in hysterectomy.5(13%) patients with normal SIS findings had abnormality in 
hysterectomy . 
  
 
TABLE 14 :  hysteroscopy Vs hysterectomy 
 HYSTERECTOMY  FINDINGS  
 0 1 Total 
HYSTERO 
SCOPY     
abn/nor 
0 Count 32 8 40 
% within HYSTERO 
SCOPY     abn/nor 
80.0% 20.0% 100.0% 
% within 
Hysterecctomy 
findings 
97.0% 13.8% 44.0% 
% of Total 35.2% 8.8% 44.0% 
1 Count 1 50 51 
% within HYSTERO 
SCOPY     abn/nor 
2.0% 98.0% 100.0% 
% within 
Hysterecctomy  
findings 
3.0% 86.2% 56.0% 
% of Total 1.1% 54.9% 56.0% 
 Total Count 33 58 91 
% within HYSTERO 
SCOPY     abn/nor 
36.3% 63.7% 100.0% 
% within 
Hysterecctomy  
findings 
100.0% 100.0% 100.0% 
% of Total 36.3% 63.7% 100.0% 
  
Chi - Square Test 
 Value Exact Sig. (2-sided) 
McNemar Test  .039a 
N of Valid Cases 91  
a. Binomial Distribution List 
Out of the 51 patients with abnormal findings on hysteroscopy 50( 98%)  
had abnormal findings in hysterectomy . 8 ( 20% ) patients with normal 
hysteroscopy findings had abnormality in hysterectomy. 
 
 
 
 
 
 
 
 
 
  
 
   Tvs vs  hysterectomy. 
Results 
 
Diagnostic or Screening Test Evaluation 
 
      
Single Table Analysis 
  
Positive Negative Total 
  
 
Positive 52 4 56 
  
  
92.9% 7.1% 100% 
  
  
89.7% 12.1%   
  
 
Negative 6 29 35 
  
  
17.1% 82.9% 100% 
  
  
10.3% 87.9%   
  
  
58 33 91 
  
  
63.7% 36.3% 100% 
  
  
100% 100% 
 
   
      
Parameter 
 
Estimate Lower - Upper 95% CIs Method 
 Sensitivity 89.66% (79.21, 95.17¹ ) Wilson Score 
Specificity 87.88% (72.67, 95.18¹ ) Wilson Score 
Positive Predictive Value 92.86% (83.02, 97.19¹ ) Wilson Score 
Negative Predictive Value 82.86% (67.32, 91.9¹ ) Wilson Score 
Diagnostic Accuracy 89.01% (80.94, 93.92¹ ) Wilson Score 
 
 
 
 
 
 
  
 
                       SIS vs., hysterectomy.  
                  Results 
 
Diagnostic or Screening Test Evaluation 
  
      
Single Table Analysis 
  
Positive Negative Total 
  
 
Positive 53 2 55 
  
  
96.4% 3.6% 100% 
  
  
91.4% 6.1%   
  
 
Negative 5 31 36 
  
  
13.9% 86.1% 100% 
  
  
8.6% 93.9%   
  
  
58 33 91 
  
  
63.7% 36.3% 100% 
  
  
100% 100% 
   
      
Parameter 
 
Estimate Lower - Upper 95% CIs Method 
 Sensitivity 91.38% (81.36, 96.26¹ ) Wilson Score 
Specificity 93.94% (80.39, 98.32¹ ) Wilson Score 
Positive Predictive Value 96.36% (87.68, 99¹ ) Wilson Score 
Negative Predictive Value 86.11% (71.34, 93.92¹ ) Wilson Score 
Diagnostic Accuracy 92.31% (84.96, 96.22¹ ) Wilson Score 
 
 
 
 
 
 
  
 
                   Hysteroscopy.   vs.  hysterectomy 
                          Results 
 
Diagnostic or Screening Test Evaluation 
  
      
 
Single Table Analysis 
  
Positive Negative Total 
  
 
Positive 50 1 51 
  
  
98% 2% 100% 
  
  
86.2% 3%   
  
 
Negative 8 32 40 
  
  
20% 80% 100% 
  
  
13.8% 97%   
  
  
58 33 91 
  
  
63.7% 36.3% 100% 
  
  
100% 100% 
   
      
Parameter 
 
Estimate Lower - Upper 95% CIs Method 
 Sensitivity 86.21% (75.07, 92.84¹ ) Wilson Score 
Specificity 96.97% (84.68, 99.46¹ ) Wilson Score 
Positive Predictive Value 98.04% (89.7, 99.65¹ ) Wilson Score 
Negative Predictive Value 80% (65.24, 89.5¹ ) Wilson Score 
Diagnostic Accuracy 90.11% (82.26, 94.71¹ ) Wilson Score 
 
 
 
 
 
 
  
 
        Hpe  vs.  hysterectomy 
      Results 
 
Diagnostic or Screening Test Evaluation 
  
      
 
Single Table Analysis 
  
Positive Negative Total 
  
 
Positive 56 1 57 
  
  
98.2% 1.8% 100% 
  
  
96.6% 3%   
  
 
Negative 2 32 34 
  
  
5.9% 94.1% 100% 
  
  
3.4% 97%   
  
  
58 33 91 
  
  
63.7% 36.3% 100% 
  
  
100% 100% 
   
      
Parameter 
 
Estimate Lower - Upper 95% CIs Method 
 Sensitivity 96.55% (88.27, 99.05¹ ) Wilson Score 
Specificity 96.97% (84.68, 99.46¹ ) Wilson Score 
Positive Predictive Value 98.25% (90.71, 99.69¹ ) Wilson Score 
Negative Predictive Value 94.12% (80.91, 98.37¹ ) Wilson Score 
Diagnostic Accuracy 96.7% (90.75, 98.87¹ ) Wilson Score 
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ROC curve 
Variable  TVS_ACTUAL 
TVS ACTUAL 
Classification variable HYS_DONE 
HYS DONE 
Positive group  
HYS DONE  = 1 
Sample size 58 
Negative group  
HYS DONE  = 0 
Sample size 33 
Disease prevalence (%)  63.7 
Area under the ROC curve (AUC)  0.961 
Standard error  0.0191 
95% Confidence interval  0.898 to 0.990 
z statistic  24.141 
Significance level P (Area=0.5) 0.0001 
 
Criterion values and coordinates of the ROC curve 
 
 
Criterion 
 
Sensitivity 
 
95% CI 
 
Specificity 
 
95% CI 
 
+LR 
 
-LR 
 
+PV 
 
-PV 
>=7 100.00 93.8 - 100.0 0.00 0.0 - 10.7 1.00   63.7   
>7 100.00 93.8 - 100.0 6.06 0.9 - 20.3 1.06 0.00 65.2 100.0 
>9 100.00 93.8 - 100.0 9.09 2.0 - 24.4 1.10 0.00 65.9 100.0 
>10 100.00 93.8 - 100.0 15.15 5.2 - 31.9 1.18 0.00 67.4 100.0 
>11 100.00 93.8 - 100.0 33.33 18.0 - 51.8 1.50 0.00 72.5 100.0 
>12 98.28 90.7 - 99.7 57.58 39.2 - 74.5 2.32 0.03 80.3 95.0 
>13 89.66 78.8 - 96.1 87.88 71.8 - 96.5 7.40 0.12 92.9 82.9 
>14 89.66 78.8 - 96.1 90.91 75.6 - 98.0 9.86 0.11 94.5 83.3 
>15 * 89.66 78.8 - 96.1 96.97 84.2 - 99.5 29.59 0.11 98.1 84.2 
>16 74.14 61.0 - 84.7 96.97 84.2 - 99.5 24.47 0.27 97.7 68.1 
>17 67.24 53.7 - 79.0 100.00 89.3 - 100.0   0.33 100.0 63.5 
>18 44.83 31.7 - 58.5 100.00 89.3 - 100.0   0.55 100.0 50.8 
>19 27.59 16.7 - 40.9 100.00 89.3 - 100.0   0.72 100.0 44.0 
>20 15.52 7.4 - 27.4 100.00 89.3 - 100.0   0.84 100.0 40.2 
>21 10.34 3.9 - 21.2 100.00 89.3 - 100.0   0.90 100.0 38.8 
>22 6.90 2.0 - 16.7 100.00 89.3 - 100.0   0.93 100.0 37.9 
>23 1.72 0.3 - 9.3 100.00 89.3 - 100.0   0.98 100.0 36.7 
>119 0.00 0.0 - 6.2 100.00 89.3 - 100.0   1.00   36.3 
 
+LR :  Positive likelihood ratio 
-LR :  Negative likelihood ratio 
+PV :  Positive predictive value 
-PV :  Negative predictive value 
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 Criterion : >13 
ROC curve 
Variable  SIS 
Classification variable HYS_DONE 
HYS DONE 
Positive group  
HYS DONE  = 1 
Sample size 58 
Negative group  
HYS DONE  = 0 
Sample size 33 
Disease prevalence (%)  63.7 
Area under the ROC curve (AUC)  0.939 
Standard error  0.0244 
95% Confidence interval  0.868 to 0.978 
z statistic  17.969 
Significance level P (Area=0.5) 0.0001 
 
Criterion values and coordinates of the ROC curve 
 
Criterion Sensitivity 95% CI Specificity 95% CI +LR -LR +PV -PV 
>=7 100.00 93.8 - 100.0 0.00 0.0 - 10.7 1.00   63.7   
>7 100.00 93.8 - 100.0 3.03 0.5 - 15.8 1.03 0.00 64.4 100.0 
>8 100.00 93.8 - 100.0 6.06 0.9 - 20.3 1.06 0.00 65.2 100.0 
>9 100.00 93.8 - 100.0 15.15 5.2 - 31.9 1.18 0.00 67.4 100.0 
>10 100.00 93.8 - 100.0 24.24 11.1 - 42.3 1.32 0.00 69.9 100.0 
>11 96.55 88.1 - 99.5 63.64 45.1 - 79.6 2.66 0.054 82.4 91.3 
>12 91.38 81.0 - 97.1 84.85 68.1 - 94.8 6.03 0.10 91.4 84.8 
>13 * 89.66 78.8 - 96.1 93.94 79.7 - 99.1 14.79 0.11 96.3 83.8 
>16 81.03 68.6 - 90.1 93.94 79.7 - 99.1 13.37 0.20 95.9 73.8 
>17 67.24 53.7 - 79.0 93.94 79.7 - 99.1 11.09 0.35 95.1 62.0 
>18 39.66 27.1 - 53.4 96.97 84.2 - 99.5 13.09 0.62 95.8 47.8 
>19 34.48 22.5 - 48.1 100.00 89.3 - 100.0   0.66 100.0 46.5 
>20 22.41 12.5 - 35.3 100.00 89.3 - 100.0   0.78 100.0 42.3 
>21 13.79 6.2 - 25.4 100.00 89.3 - 100.0   0.86 100.0 39.8 
>22 8.62 2.9 - 19.0 100.00 89.3 - 100.0   0.91 100.0 38.4 
>23 5.17 1.1 - 14.4 100.00 89.3 - 100.0   0.95 100.0 37.5 
>24 0.00 0.0 - 6.2 100.00 89.3 - 100.0   1.00   36.3 
 
 
 
 
 
 
 
 
+LR :  Positive likelihood ratio 
-LR :  Negative likelihood ratio 
+PV :  Positive predictive value 
-PV :  Negative predictive value 
DISCUSSION 
 
Considering the following studies supporting SIS as a successful 
procedure Alborzis et al.,55 in 2007, Compared the accuracy of saline infusion 
sonohysterography with transvaginal sonography for the screening of causes of 
abnormal uterine bleeding in outpatients.81 patients with AUB were studied. 
All cases who were examined with TVS, were further investigated with SIS 
using saline as contrast medium, finally hysteroscopy was used as the gold 
standard. 
TVS Sensitivity - 72% 
Specificity - 92% 
PPV - 94% 
NPV - 65% 
SIS Sensitivity - 94.1% 
Specificity - 95% 
PPV - 96% 
NPV - 90% 
TVS had Kappa measure of agreement of 0.60 while 0.86 was reported 
for SIS, so in this study SIS was more sensitive and specific in diagnosing 
polyp and myoma with high positive and negative predictive value. 
Van Dongen H, et al.,56 de Karoon CD et al., in 2008, did a comparison 
of patient discomfort during SIS and vaginoscopic office hysteroscopy. 
The success rate, defined as adequate inspection of the cervical canal 
and the uterine cavity was 94% for SIS compared with 92% for office 
hysteroscopy (p = 0.633) SIS, multiparity, shorter procedure time and position 
of the uterus in anti version decreased pain scores among women studied. They 
concluded that both SIS and office hysteroscopy are successful procedures and 
well tolerated by women. SIS induces significantly less discomfort than office 
hysteroscopy and should therefore be considered the method of choice.  
In our  prospective study analyzing the diagnostic accuracy of 
transvaginal ultrasound with Sonohysterography and hysteroscopy for the 
screening of intracavitary pathologies in abnormal uterine bleeding was 
undertaken in 200 patients at ISO-KGH Chennai. The results of this study is 
discussed below: 
• Table 1,2,3,&4 shows that abnormal findings in SIS was found in 55 
patients, 56 patients had abnormal findings in TVS, 51 patients had 
abnormal hysteroscopy findings  and mean age group of abnormal 
findings  was found to be 41 yrs in our study. 
•  The mean duration of complaints among the abnormal group was seven 
months 
• Among the 200 patients 144 patients were found to have normal 
findings on both TVS and145 on  SIS. 
•  TVS detected 40 cases of EM hyperplasia 10 cases of EM polyps and 6 
cases of submucous fibroids (SMF) 
• SIS findings were 14 cases of EM hyperplasia, 22 cases of EM polyp 
and 5 cases of SMF . 
•  the findings with hysteroscopy were 26 cases of EM hyperplasia, 19 
cases of polyp and 2 cases of SMF 
• Out of the 55 patients with abnormal SIS 53(96%) had abnormal 
findings in hysterectomy whereas 5cases (13%) with normal SIS had 
abnormalities in hysterectomy  
• Out of the 56 patients with abnormal TVS 52(92%) had abnormal 
findings in hysterectomy whereas 6 cases (17%) with normal TVS had 
abnormalities in hysterectomy  
• Out of the 51 patients with abnormal HYSTEROSCOPY 50(98%) had 
abnormal findings in hysterectomy whereas 8cases (20%) with normal 
HYSTERSCOPY had abnormalities in hysterectomy  
• The sensitivity,specificity and diagnostic accuracy of TVS are 89%  
87% and 89% respectively.whereas that for SIS 91%  93%  AND 92%  
which is higher 
• The sensitivity of hysteroscopy wa 86%s less than the above modalities  
but has a high  specificity 98% and positive predictive value of 
98%..however the diagnostic accuracy is 90% 
• In this study 14mm cut off was taken for  endometrial 
hyperplasia..analysing our data under the ROC curve a 13mm cutoff on 
SIS shows sensitivity of 89% and specificity of 93% whereas 15 mm 
cutoff on TVS improves  the specificity  to 97%to detect endometrial 
lesions. 
• Out of the 100 patients who had previous h/o AUB ,32 patients had 
abnormal TVS findings whereas 68 patients had normal TVS 
• Out of the 100 patients who had previous h/o AUB ,30 patients had 
abnormal SIS findings whereas 70 patients had normal SIS. 
• Out of the 100 patients who had previous h/o AUB ,29 patients had 
abnormal HYSTEROSCOPY findings whereas 71 patients had normal 
HYSTEROSCOPY findings 
• Out of the 100 patients who had previous h/o AUB, 66 patients had 
abnormal hpe findings whereas 34 patients had normal hpe findings. 
 
 
 
 
 
 
 
 
SUMMARY 
This is a prospective study to evaluate the diagnostic accuracy of 
transvaginal ultrasonogram with sonohysterography and hysteroscopy for the 
screening of intracavitary pathologies in women with abnormal uterine 
bleeding and to correlate the findings with the histopathological specimens of 
the endometrium obtained by dilation and curettage or hysterectomy conducted 
at ISO-KGH,Chennai 
Study period was 1 year sep2010 to aug 2011 
The study included 200 women who had come to the Institute of Social 
Obstetrics and Government Kasturba Gandhi hospital with complaints of 
abnormal uterine bleeding were selected, admitted and subjected for 
transvaginal ultrasonogram followed by sonohysteroography using saline 
instilled through an endocervically placed catheter in sequence of the same day 
of admission. 24 hours later diagnostic hysteroscopy was performed under 
intravenous sedation and endometrial tissue collected for histology by 
D&C/directed biopsies .Among the 200 patients in the study group 91 patients 
underwent hysterectomy  (i.e) those patients who had abnormal findings in the 
above investigations and also for  patients  with h/o long standing AUB not 
ready for regular follow up.  who wanted hysterectomy  
The findings of TVS,SIS and hysteroscopy were correlated with hysterectomy 
which is considered the gold standard  and the diagnostic accuracy of 
individual tests was evaluated..  
 
CONCLUSION 
 
 
• Among the 200 patientswith AUB  in our study group,  abnormal 
findings was found in the mean age group of 41 years. 
• Mean duration of complaint among the patients with abnormal findings 
was 7 months in our study . 
• In our study ,TVS detected 92% abnormalities whereas 17% false 
negative results were found comparing with gold standard 
hysterectomy. 
• SIS detected  96% abnormalities and13% false negative  which is better 
than that of the TVS . 
• Hysteroscopy showed high positive predictive value 98% however the 
false negativity was 20% in our study. suggesting SIS as a better 
modality than the other two investigations. 
• Hysteroscopy had high positive predictive value 98% but sensitivity 
was low 86% and  diagnostic accuracy 90%.. 
• SIS has highest diagnostic accuracy 92%  and negative predictive  value 
86%.this concludes that there is an improved demonstration of 
endometrial polyps and submucousmyomas using saline enhanced           
vaginal sonohysterography. 
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PROFORMA 
 
Name : 
Age : 
In patient Number : 
Socio-Economic status : 
Literacy : 
Occupation : 
Place : 
Married since : 
Parity : 
Time since Last child birth : 
Sterilization : 
Last Menstrual Period : 
Presenting Complaints of : 
Pattern of bleeding : 
Number of diapers/day : 
Last menstrual Period : 
Any History of (H/o) passing clots : 
Past menstrual History : 
Prior treatment with hormones : 
Prior Dilatation and Curettage : 
Other presenting complaints : 
H/o white discharge per vaginum : 
Scanty or profuse : 
Blood stained : 
Itching/ foul smelling : 
H/o post coital bleeding : 
H/o pain abdomen in relation to menses: 
H/o burning micturition : 
H/o drug intake : 
H/o endocrine disorders : 
 
Menstrual History 
H/o Regularity of menstrual period : 
How many pads/day? 
Cycle length 
Duration of flow 
 
Marital and obstetric history 
Married since : 
Parity, Live, Abortion (spontaneous/ induced): 
Contraception History 
Temporary methods – 
Oral contraceptive pills : 
Barrier methods : 
Intra Uterine Contraceptive Device: 
Natural methods: 
Permanent methods : 
Puerperal Sterilization: 
Medical termination of pregnancy with trans abdominal tubectomy: 
Medical termination of pregnancy with Laparoscopy sterilization : 
Interval Laparoscopy sterilization 
No contraception: 
Past medical/ surgical History : 
Hypertension, Diabetes mellitus, Tuberculosis, Asthma, bleeding 
disorders, any surgery 
General examination 
• Weight 
• Built/Nourishment 
• Anaemia 
• Pedal edema 
• Thyroid ,spine, breast 
• Vital signs pulse rate 
blood pressure 
temperature 
respiratory rate 
Cardio vascular system 
Respiratory system 
Per abdomen 
Per speculum 
Per vaginum 
 
INVESTIGATIONS 
Urine Routine 
Complete Hemogram with platelet count 
Blood sugar 
Blood urea 
Chest x-ray ,Electrocardiography  
Informed consent for hysteroscopy 
Trans vaginal sonography findings 
Salinesonohysterogram findings 
Hysteroscopy findings 
Histopathologic examination findings 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Master Chart 
 
 
 
 
 
 
 
S.No NAME AGE  Age 
Group 
DUR
ATIO
N OF 
COM
PLAI
NT in 
mont
hs 
Previo
us h/o 
AUB 
TVS 
actual 
value{m
m} 
Tvs TVS SIS Sis  SIS Hystsc
opy         
types 
HYSTEROS
COPY 
Hpe 
nor/ab
n 
HPE on 
D&C 
Hyste
recct
omy 
done/
not 
done 
Hystr
ecto
my 
types 
hyster
ectom
y types findings Actua
l 
value 
types findings 
1 LAKSHMI 30 1 8 1 8 0 norm 7 0 norm 0 norm 0 proEM 9     
2 AMBIKA 42 4 9 1 6 0 norm 8 0 norm 0 norm 0 proEM 9     
3 GRACE 34 2 7 0 4 0 norm 5 0 norm 0 norm 0 proEM 9     
1 SHEEBA 44 4 8 0 6 0 norm 6 0 norm 0 norm 0 proEM 9     
5 LALITHA 44 4 9 0 6 0 norm 6 0 norm 0 norm 0 proEM 9     
6 LILLY 33 2 6 0 9 0 norm 8 0 norm 0 norm 0 proEM 9     
7 JEBA 43 4 5 0 16 1 EMhy 18 1 EMhy 1 EMhy 1 EMpol 1 3 EMpol 
8 RAMYA 41 4 6 0 6 0 norm 7 0 norm 0 norm 1 proEM 9     
9 FATHIMA 40 4 4 0 8 0 norm 7 0 norm 0 norm 0 proEM 9     
10 PRIYA 41 4 7 0 22 2 EMhy 24 2 EMpol 0 Norm 1 EMpol 1 3 EMpol 
11 DEVI 39 3 6 1 7 0 norm 6 0 norm 0 norm 0 proEM 9     
12 ANNAM 38 3 8 1 9 0 norm 7 0 norm 0 norm 0 proEM 9     
13 VEMBU 37 3 6 1 9 0 norm 7 0 norm 0 norm 0 proEM 9     
14 KANIKA 43 4   1 20 1 EMhy 20 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
15 VANI 35 2 4 0 6 0 norm 8 0 norm 0 norm 0 proEM 9     
16 NITHIYA 44 4 5 0 8 0 norm 9 0 norm 0 norm 0 proEM 9     
17 RAJI 45 4 7 0 8 0 norm 9 0 norm 0 norm 0 proEM 9     
18 DIVIYA 42 4 8 0 17 1 EMhy 19 1 EMhy 2 EMpol 0 proEM 0 5 proEM 
19 PUSHPA 41 4 9 0 11 0 norm 9 0 norm 0 norm 0 proEM 9     
20 USHA 42 4 8 1 23 1 EMhy 23 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
21 MARIAM 39 3 9 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
22 ANITHA  44 4 6 1 17 1 EMhy 19 2 EMpol 0 norm 1 EMpol 1 3 EMpol 
23 AMBIKA 38 3 7 1 8 0 norm 7 0 nor1m 0 norm 0 proEM 9     
24 SATHIYA 36 3 8 0 9 0 norm 7 0 norm 0 norm 0 proEM 9     
25 VANI 43 4 7 0 16 1 EMhy 16 1 EMhy 0 norm 1 SH 1 1 SH 
26 MANJU 37 3 7 0 8 0 norm 6 0 norm 0 norm 0 proEM 9     
27 RAJI 45 4 7 0 9 0 norm 8 0 norm 0 norm 0 proEM 9     
28 KUMARI 43 4 8 0 11 0 norm 9 0 norm 0 norm 0 proEM 9     
29 NATHIYA 43 4 7 0 12 0 norm 10 0 norm 0 norm 0 proEM 0 5 Proem 
30 KOWSEI 39 3 7 0 11 0 norm 9 0 norm 0 norm 0 proEM 9     
31 KAIALB 38 3 6 0 10 0 norm 9 0 norm 0 norm 0 proEM 9     
32 BHARTHI 43 4 6 0 20 1 EMhy 18 1 EMhy 1 EMhy 1 SH A 1 1 SH A 
33 THARANI 40 3 6 0 9 0 norm 7 0 norm 0 norm 0 proEM 9     
34 KGUMARI 44 4 6 0 11 0 norm 9 0 norm 0 norm 0 proEM 0 5 proEM 
35 ANITHA 45 4 7 0 11 0 norm 9 0 norm 0 norm 0 proEM 9     
36 SUJI 36 3 6 0 9 0 norm 9 0 norm 0 norm 0 proEM 9     
37 VALI 40 3 6 0 23 1 EMhy 24 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
38 REMYA 41 4 6 0 9 0 norm 8 0 No0rm 0 norm 0 proEM 9     
39 SHYNI 35 2 6 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
40 BLESSY 38 3 6 0 8 0 norm 8 0 norm 0 norm 0 secEM 9     
41 JAMILA 43 4 6 0 13 0 norm 12 0 norm 0 norm 0 proEM 0 5 proEM 
42 MALIKA 37 3 6 0 12 0 norm 12 0 norm 0 norm 0 proEM 9     
43 SHANTHI 42 4 8 0 16 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
44 JAYA 37 3 8 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
45 MARY 39 3 8 0 22 1 EMhy 24 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
46 MALI 38 3 8 0 8 0 norm 7 0 norm 0 norm 0 proEM 9     
47 RAJI 41 4 8 0 23 2 EMpol 23 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
48 SHEELA 44 4 8 1 13 0 norm 12 0 norm 0 norm 0 proEM 0 5 proEM 
49 RAGA 38 3 8 1 9 0 norm 8 0 norm 0 norm 0 proEM 9     
50 AJIM 41 4 8 1 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
51 JAYA 40 3 9 1 9 0 norm 9 0 norm 0 norm 0 proEM 9     
52 ELAVARASI 45 4 11 1 9 0 norm 9 0 norm 0 norm 0 proEM 9     
53 LENI MARY 43 4 11 1 18 1 EMhy 18 1 EMhy 1 EMhy 1 CH 1 2 CH 
54 JANCY 43 4 12 0 13 0 norm 12 0 norm 0 norm 0 proEM 9     
55 ALMELU 43 4 12 0 21 2 EMpol 22 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
56 SHALINI 39 3 13 0 13 0 norm 13 0 norm 0 norm 0 proEM 0 5 proEM 
57 RATHNA 44 4 6 0 12 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
58 SIVRANJANI 42 4 6 0 20 1 EMhy 22 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
59 JANCYRANI 30 1 6 0 9 0 norm 8 0 norm 0 norm 0 proEM 9     
60 KALIVANI 43 4 6 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
61 NANTHINI 42 4 8 1 21 2 EMpol 21 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
62 KANMANI 30 1 8 1 8 0 norm 9 0 norm 0 norm 0 proEM 9     
63 SAROJA 43 4 8 1 19 1 EMhy 20 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
64 GAYATHRI 43 4 8 1 9 0 norm 8 0 norm 0 norm 0 proEM 9     
65 KAVITHA 40 3 8 1 8 0 norm 8 0 norm 0 norm 0 secEM 9     
66 KANIKA 44 4 8 1 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
67 CLARA 34 2 9 1 9 0 norm 7 0 nor1m 0 norm 0 proEM 9     
68 SHEELA 42 4 9 1 20 2 EMpol 21 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
69 THARA 44 4 9 1 20 2 EMpol 21 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
70 PUSPHA 45 4 9 1 19 1 EMhy 17 1 EMhy 1 EMhy 1 SH 1 1 SH 
71 THARA 43 4 14 1 11 0 norm 10 0 norm 0 norm 0 proEM 9     
72 SOBANA 32 2 4 1 8 0 norm 7 0 norm 0 norm 0 proEM 9     
73 KAVIYA 41 4 14 1 6 0 norm 7 0 norm 0 norm 0 proEM 9     
74 priya 38 3 6 0 8 0 norm 8 0 norm 0 norm 0 proEM 9 
    
75 KIRTHEEKA 41 4 15 1 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
76 JAYANTHI 39 3 15 1 9 0 norm 9 0 norm 0 norm 0 proEM 9     
77 SOLOKCHANA 37 3 9 1 4 0 norm 6 0 norm 0 norm 0 proEM 9     
78 SUGANTHI 31 2 9 1 7 0 norm 6 0 norm 0 norm 0 proEM 9     
79 MALARGODI 45 4 9 1 19 2 EMpol 20 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
80 RAVATHI 39 4 9 1 9 0 norm 9 0 norm 0 norm 0 proEM 9     
81 SUGANYA 43 4 9 1 7 0 norm 8 0 norm 0 norm 0 proEM 9     
82 RATHIKA 42 4 7 1 11 0 norm 11 0 norm 0 norm 0 proem 0 5 proEM 
83 SANGEETHA 31 2 7 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
84 CHANDRA 41 4 7 0 8 0 norm 7 0 norm 0 norm 0 proEM 9     
85 MANGALA 38 3 7 0 12 0 norm 12 0 norm 0 norm 0 proEM 0 5 proEM 
86 MANOGARI 42 4 7 0 9 0 norm 9 0 norm 0 norm 0 proEM 9     
87 SUBULAKSHIMI 41 4 7 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
88 JAYALAKSHM 39 3 7 0 16 1 EMhy 16 1 EMhy 1 EMhy 1 SH 1 1 SH 
89 RAJALAKSHMI 39 3 6 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
90 NATHIYA 32 3 6 0 18 1 EMhy 17 1 EMhy 1 EMhy 1 SH 1 1 SH 
91 DIVYA 38 3 3 0 6 0 norm 7 0 norm 0 norm 0 proEM 9     
92 KALAYANI 37 3 3 0 12 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
93 CHITHRA 42 4 3 0 13 0 norm 12 0 norm 0 norm 0 proEM 0 5 proEM 
94 KAVITHA 39 3 3 0 4 0 norm 4 0 norm 0 norm 0 proEM 9     
95 KRISHNAVENI 36 3 4 0 16 1 EMhy 16 1 EMhy 1 EMhy 1 SH 1 1 SH 
96 ANUSHYA 43 4 4 0 13 0 norm 12 0 norm 0 norm 0 proEM 0 5 proEM 
97 PRIYA 34 2 4 0 7 0 norm 8 0 norm 0 norm 0 proEM 9     
98 AMMU 37 3 4 0 16 1 EMhy 16 1 EMhy 0 norm 1 SH 1 1 SH 
99 ANIJA 42 4 6 0 8 0 norm 7 0 norm 0 norm 0 proEM 9     
100 PONMANI 42 4 7 1 20 1 EMhy 21 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
101 SEETHA 35 2 6 1 6 0 norm 8 0 norm 0 norm 0 proEM 9     
102 RANI 40 3 9 1 5 0 norm 6 0 norm 0 norm 0 proEM 9     
103 SUDHA 45 4 9 1 12 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
104 KAMACHI 40 3 9 1 8 0 norm 9 0 norm 0 norm 0 proEM 9     
105 ROSI 40 3 9 1 6 0 norm 5 0 norm 0 norm 0 proEM 9     
106 SANTHA 45 4 10 1 13 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
107 LAVANYA 41 4 10 1 7 0 norm 7 0 norm 0 norm 0 secEM 9     
108 SWEETY 41 4 5 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
109 PRADEEPA 41 4 6 1 17 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
110 RENUGA 41 4 7 1 8 0 norm 8 0 norm 0 norm 0 proEM 9     
111 ANITHA 40 3 5 1 8 0 norm 8 0 norm 0 norm 0 proEM 9     
112 SAVEETHA 39 3 6 1 8 0 norm 8 0 norm 0 norm 0 proEM 9     
113 BARANI 42 4 7 1 16 1 EMhy 17 1 EMhy 1 EMhy 1 SH 1 1 SH 
114 PAVITHRA 45 4 5 1 19 1 EMhy 20 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
115 RAJAKUMARI 39 3 6 1 8 0 norm 8 0 norm 0 norm 0 proEM 9     
116 DEEPA 42 4 7 1 12 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
117 MUNIYAMMA 39 3 6 1 8 0 norm 8 0 norm 0 norm 0 proEM 9     
118 ANNAMALAI 43 4 6 1 11 0 norm 11 0 norm 0 norm 0 proEM 9     
119 KASTURI 42 4 6 1 19 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
120 SELI 39 3 6 1 6 0 norm 7 0 norm 0 norm 0 proEM 9     
121 NARMATHA 39 3 6 1 5 0 norm 6 0 norm 0 norm 0 proEM 9     
122 AMBIKA 40 3 6 1 16 1 EMhy 16 1 EMhy 1 EMhy 1 SH 1 1 SH 
123 SARITHA 40 3 6 1 4 0 norm 5 0 norm 0 norm 0 proEM 9     
124 DAHNALAKSHMI 42 4 8 0 3 0 norm 5 0 norm 0 norm 1 proEM 9     
125 SATHYA 41 4 6 0 7 0 norm 7 0 norm 0 norm 0 proEM 9     
126 MAGESHWARI 40 3 9 0 17 1 EMhy 17 1 EMhy 1 norm 1 EMpol 1 3 EMpol 
127 UMA 43 4 6 0 13 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
128 VIJAYALAKSH 42 4 7 1 13 0 norm 11 0 norm 0 norm 1 proEM 0 5 proEM 
129 SHYLAJA 40 3 7 1 119 1 EMhy 20 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
130 SRIDEVI 34 2 6 1 7 0 norm 8 0 norm 0 norm 0 proEM 9     
131 MALATH 45 4 6 1 6 0 norm 7 0 norm 0 norm 0 proEM 9     
132 SATHYAPRIYA 36 3 6 1 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
133 KOSALYA 42 4 6 0 7 0 norm 7 0 norm 0 norm 0 proEM 9     
134 MALAR 40 3 6 0 12 0 norm 11 0 norm 0 norm 0 proEM 9     
135 DEVIPRIYA 41 4 6 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
136 VANI 44 4 8 0 5 0 norm 6 0 norm 0 norm 0 proEM 9     
137 INDU 37 3 8 0 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
138 RAGA 42 4 8 0 5 0 norm 6 0 norm 0 norm 0 proEM 9     
139 RAGAMATH 
NISHA 
40 3 9 0 13 0 norm 13 0 norm 0 norm 0 proEM 0 5 proEM 
140 RASATHI 41 4 9 0 4 0 norm 5 0 norm 0 norm 0 proEM 9     
141 PADMA 40 3 9 0 10 0 norm 9 0 norm 0 norm 0 proEM 9     
142 BAKYA 45 4 8 0 17 1 EMhy 17 1 EMhy 1 EMhy 1 SH 1 1 SH 
143 PARAMESHWARI 43 4 9 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
144 VALAR 44 4 8 0 5 0 norm 6 0 norm 0 norm 0 proEM 9     
145 MURUGESHWARI 40 3 8 1 12 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
146 SUNDARI 42 4 7 1 7 0 norm 8 0 norm 0 norm 0 proEM 9     
147 PODUMPONA 44 4 6 1 11 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
148 MANIMEGALAI 39 3 6 1 6 0 norm 6 0 norm 0 norm 0 proEM 9     
149 GANASUNDARI 40 3 6 1 10 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
150 UMA 35 2 7 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
151 VENODINI 36 3 6 1 6 0 norm 7 0 norm 0 norm 0 proEM 9     
152 PRABA 38 3 6 1 18 1 EMhy 17 1 EMhy 1 EMhy 1 CH 1 2 CH 
153 IYAMMA 32 2 6 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
154 UNAMALI 33 2 9 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
155 devagi 36 3 6 1 6 0 norm 6 0 norm 0 norm 0 proEM 9     
156 RADIKA 42 4 9 1 20 1 EMhy 21 2 EMpol 3 SMfb 1 EMpol 1 3 EMpol 
157 SASIKALA 36 3 8 1 5 0 norm 6 0 norm 0 norm 0 SecEM 9     
158 PONGODI 32 2 8 1 5 0 norm 6 0 norm 0 norm 1 SecEM 9     
159 USHA RANI 40 3 7 1 13 0 Norm 11 2 EMpol 2 EMpol 1 SH 1 3 EMpol 
160 KAMACHI 39 3 5 1 21 3 SMfb 22 3 SMfb 3 SMfb 1 SH 1 4 SMfb 
161 ARULMOZIL 32 2 6 0 7 0 norm 7 0 norm 0 norm 0 proEM 9     
162 MARVIZLI 43 4 7 0 11 0 norm 10 0 norm 0 norm 0 proEM 0 5 proEM 
163 GOMATHIDEVAKI 31 2 8 0 8 0 norm 9 0 norm 0 norm 0 proEM 9     
164 RAMANI 40 3 6 0 19 1 EMhy 18 1 EMhy 1 EMhy 1 EMpol 1 3 EMpol 
165 VENILA 32 2 7 0 8 0 norm 7 0 norm 0 norm 0 proEM 9     
166 MYTHILI 31 2 6 0 6 0 norm 7 0 norm 0 norm 0 proEM 9     
167 RENUKA 44 4 6 0 12 0 norm 9 0 norm 0 norm 0 proEM 0 5 proEM 
168 AMUTHA 40 3 7 0 13 0 norm 13 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
169 KARPAKAM 40 3 6 0 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH  
170 MEEANKSHI 39 2 5 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
171 RASATHI 39 2 8 0 7 0 norm 8 0 norm 0 norm 0 proEM 0 5 proEM 
172 KANAMMA 38 2 9 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
173 KUMUTHA 42 4 6 0 11 0 norm 11 0 norm 0 norm 0 proEM 0 5 proEM 
174 RANI 34 2 8 0 7 0 norm 7 0 norm 0 norm 0 proEM 9     
175 RAMA 44 4 8 0 10 0 norm 10 0 norm 0 norm 0 proEM 0 5 proEM 
176 KUMARI 39 3 8 1 18 1 EMhy 18 1 EMhy 1 EMhy 1 SH 1 1 SH 
177 MANIMEGALI 44 4 9 1 11 0 norm 11 0 norm 0 Norm 0 proEM 0 5 proEM 
178 SIVAGAMI 36 3 6 1 11 0 norm 11 0 norm 0 norm 0 proEM 9     
179 SUSILLA 42 4 6 1 19 3 SMfb 20 3 SMfb 3 SMfb 1 SMfb 1 4 SMfb 
180 ESWARI 35 2 8 1 7 0 norm 7 0 norm 0 norm 0 proEM 9     
181 THENMIZOHI 36 3 6 1 8 0 norm 8 0 norm 0 norm 0 proEM 9     
182 JAMUNA 40 3 8 0 18 1 EMhy 18 1 EMhy 1 EMhy 1 EMpol 1 3 EMpol 
183 VASANTHI 43 4 6 0 13 0 norm 12 0 norm 0 normal 0 proEM 1 4 SMfb 
184 SETALLA 37 3 7 0 18 3 SMfb 17 2 EMpol 2 EMpol 1 EMpol 1 3 EMpol 
185 VIJAYA 43 4 6 0 19 3 SMfb 19 3 SMfb 3 SMfb 1 EMpol 1 3 EMpol 
186 HEMAVATHI 39 3 6 0 8 0 norm 8 0 norm 0 norm 0 proEM 9     
187 JEROM 38 3 7 0 18 2 EMpol 17 1 EMhy 1 EMhy 1 SH 1 1 SH 
188 CELLIN 42 4 8 0 7 0 norm 7 0 norm 0 norm 0 proEM 0 5 proEM 
189 SUSEELA 44 4 6 0 9 0 norm 9 0 no0rm 0 norm 0 proEM 0 5 proEM 
190 JANAKI 43 4 8 1 19 2 EMpol 19 1 EMhy 1 EMhy 1 SH 1 1 SH 
191 SUDHA 43 4 6 1 13 0 norm 12 0 norm 0 norm 0 proEM 0 5 proEM 
192 PARVEEN 39 3 6 1 14 1 EMhy 12 0 norm 0 norm 0 proEM 0 5 proEM 
193 DURGADEVI 44 4 6 1 12 0 norm 12 0 norm 0 norm 0 proEM 1 3 EMpol 
194 AYSHA 44 4 7 1 13 0 norm 12 0 norm 0 norm 1 SMfb 1 4 SMfb 
195 INDUMATHI 43 4 8 1 19 3 SMfb 20 3 SMfb 0 norm 1 SMfb 1 4 SMfb 
196 BAKYAVATHI 39 3 8 1 7 0 norm 7 0 norm 0 norm 0 SecEM 9     
197 VALLI 43 4 8 1 15 2 EMpol 13 0 norm 0 norm  0 proEM 0 5 proEM 
198 SALIMA 42 4 6 1 16 1 EMhy 18 3 SMfb 3 SMfb 1 SMfb 1 4 SMfb 
199 BOMMI 45 4 6 1 13 0 norm 11 0 norm 0 norm 1 SMfb 1 4 SMfb 
200 FLORA 43 4 6 1 15 3 SMfb 18 2 EMpol 0 norm 0 proEM 0 5 proEM 
 
 
